Senescence is therefore considered, at least in part, a cancer suppression response, as carcinogenic mutations can induce oncogene-induced senescence (OIS) in cells via at least two tumor suppressor pathways: p21/p53 and the pRb/p16Ink4a signaling pathways. This evidence concerns the gene CDKN2A and cancer.